Exosomal circRNAs in the plasma serve as novel biomarkers for IPF diagnosis and progression prediction

Wenhua Gan,Wenwen Song,Yujuan Gao,Xuexue Zheng,Fengjuan Wang,Zirui Zhang,Ke Zen,Hongwei Liang,Xin Yan
DOI: https://doi.org/10.1186/s12967-024-05034-9
IF: 8.44
2024-03-12
Journal of Translational Medicine
Abstract:Idiopathic Pulmonary Fibrosis (IPF) is a type of chronic interstitial pneumonia, often fatal, with elusive causes and a bleak prognosis. Its treatment options are limited and largely ineffective. Early detection and precise diagnosis are pivotal in managing the disease effectively and enhancing patient survival rates. Recently, the quest for trustworthy biomarkers for IPF has gained momentum. Notably, emerging studies indicate that circular RNAs (circRNAs) found in exosomes may hold significant potential as valuable diagnostic markers.
medicine, research & experimental
What problem does this paper attempt to address?
This paper aims to address the issues of early diagnosis and disease progression prediction of idiopathic pulmonary fibrosis (IPF). IPF is a fatal chronic interstitial pneumonia with unknown etiology and poor prognosis. Currently, treatment options are limited and ineffective, making early detection and accurate diagnosis crucial for effective management and improving patient survival rates. The paper attempts to improve the diagnosis and progression prediction of IPF by studying circular RNAs (circRNAs) in plasma exosomes as new biomarkers. The authors first utilized human circular RNA microarray technology to explore the expression profiles of circRNAs in exosomes from the blood of IPF patients and healthy controls. They validated the differentially expressed circRNAs discovered during the training phase using real-time quantitative PCR (RT-qPCR). Finally, they validated three significantly elevated circRNAs (hsa_circ_0044226, hsa_circ_0004099, and hsa_circ_0008898) in a larger cohort. The results indicated that these circRNAs were significantly upregulated in the plasma exosomes of IPF patients, and the expression level of hsa_circ_0044226 was higher in patients with acute exacerbation (AE-IPF), suggesting its potential as a marker for predicting IPF progression. Additionally, the study further confirmed the function of hsa_circ_0044226 and its role in IPF progression through a series of in vivo and in vitro experiments. These findings provide new potential targets for the early diagnosis and treatment of IPF.